|Bid||73.12 x 200|
|Ask||73.57 x 200|
|Day's Range||72.65 - 73.76|
|52 Week Range||63.76 - 82.10|
|PE Ratio (TTM)||7.75|
|Dividend & Yield||2.08 (2.87%)|
|1y Target Est||N/A|
AbbVie is a better dividend stock than Gilead Sciences for obvious and not-so-obvious reasons.
Alkermes (ALKS) initiated the rolling submission of a New Drug Application (NDA) to the FDA for pipeline candidate ALKS 5461 for major depressive disorder.
Here is a look at four biotech stocks including Gilead (GILD) that topped estimates in Q2 and are witnessing upward estimate revisions for the current year.